Niki BioSolutions, Inc. (NIKI) Invested Capital (2017 - 2022)

Niki BioSolutions (NIKI) has 6 years of Invested Capital data on file, last reported at $3.0 million in Q4 2022.

• Quarterly Invested Capital rose 26241.21% year-over-year to $3.0 million in Q4 2022, while the trailing twelve-month figure through May 2024 was $3.0 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, up 5.56% from the prior year.
• Invested Capital steadied at $3.0 million in Q4 2022, from $3.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $47.5 billion in Q2 2020 to a low of $11389.0 in Q4 2021.
• A 5-year average of $5.3 billion and a median of $112013.0 in 2020 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2019 — Invested Capital slumped 99.69% — and 2022, when it jumped 26241.21%.
• Tracing NIKI's Invested Capital over 5 years: stood at $13.5 million in 2018, then tumbled by 99.69% to $41593.0 in 2019, then soared by 133.98% to $97319.0 in 2020, then plunged by 88.3% to $11389.0 in 2021, then jumped by 26241.21% to $3.0 million in 2022.
• The last three Invested Capital figures came in at $3.0 million (Q4 2022), $3.0 million (Q2 2022), and $11389.0 (Q4 2021), per Business Quant data.